Skip to main content
    O

    Omada Health, Inc. Common Stock (OMDA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $14.33
    -0.37 (-2.52%)

    Market Cap: $889.00M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Omada Health, Inc. Common Stock (OMDA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Omada Health, Inc. Common Stock (OMDA) to earn $0.58 per share in the fiscal year ending Dec 31, 2026, on revenue of $345.18M. Of 12 analysts, 10 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 5 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 83% of the ratings.

    RatingAnalystsShare
    Strong Buy541.7%
    Buy541.7%
    Hold216.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 13.8% and revenue estimates rise 19.2%.

    Fiscal year ending Dec 31, 2026
    $0.58
    EPS consensus, revenue $345.18M
    Fiscal year ending Dec 31, 2027
    $0.66
    EPS consensus, revenue $411.48M
    Next report
    Mar 3, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.58$0.49 to $0.644$345.18M$344.42M to $346.00M9
    Dec 31, 2027$0.66$0.47 to $0.795$411.48M$404.00M to $419.00M11

    Quarterly Estimates

    The EPS consensus rises from $0.05 for the quarter ending Dec 31, 2026 to $0.08 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.05-$0.01 to $0.0913$89.50M$84.67M to $93.14M13
    Mar 31, 2027$0.08$0.08 to $0.081$95.12M$88.30M to $103.16M7

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 9 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202650
    Fiscal year ending Dec 31, 202730
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 31.8% from $0.44.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.58$0.44$0.44$0.44$0.44+31.1%
    Fiscal year ending Dec 31, 2027$0.66$0.56$0.56$0.56$0.53+25.0%
    Quarter ending Mar 31, 2027$0.08$0.08$0.08$0.08$0.08+7.8%

    Frequently Asked Questions About OMDA

    What is the OMDA stock forecast?

    Consensus analyst estimates put Omada Health, Inc. Common Stock's EPS at $0.58 for the fiscal year ending Dec 31, 2026, on revenue of $345.18M. The consensus rating from 12 analysts is Buy.

    How do analysts rate OMDA stock?

    Of 12 analysts covering Omada Health, Inc. Common Stock, 5 rate it Strong Buy, 5 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from OMDA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.58, with estimates from $0.49 to $0.64 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.66, with estimates from $0.47 to $0.79 from 5 analysts.

    What revenue do analysts expect from Omada Health, Inc. Common Stock next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $345.18M, with estimates from $344.42M to $346.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $411.48M, with estimates from $404.00M to $419.00M.

    How many analysts cover OMDA?

    12 analysts rate Omada Health, Inc. Common Stock stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.